Form 8-K - Current report:
SEC Accession No. 0001193125-25-139150
Filing Date
2025-06-11
Accepted
2025-06-11 16:15:16
Documents
12
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d935254d8k.htm   iXBRL 8-K 35251
  Complete submission text file 0001193125-25-139150.txt   145959

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atra-20250610.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20250610_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20250610_pre.xml EX-101.PRE 10815
14 EXTRACTED XBRL INSTANCE DOCUMENT d935254d8k_htm.xml XML 3515
Mailing Address 1280 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320
Business Address 1280 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320 805-623-4211
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 251040178
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)